scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023160902 |
P356 | DOI | 10.1186/S13045-015-0150-4 |
P932 | PMC publication ID | 4455972 |
P698 | PubMed publication ID | 26021873 |
P5875 | ResearchGate publication ID | 277406830 |
P50 | author | Xiao-Dong Zhu | Q83249510 |
P2093 | author name string | Yuan-Yuan Zhang | |
Ning Zhang | |||
Jian Kong | |||
Dong-Mei Gao | |||
Hao Cai | |||
Hui-Chuan Sun | |||
Wen-Quan Wang | |||
Zong-Tao Chai | |||
Bo-Gen Ye | |||
Jian-Yang Ao | |||
De-Ning Ma | |||
P2860 | cites work | miR-126 regulates angiogenic signaling and vascular integrity | Q24569770 |
MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 | ||
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression | Q26863784 | ||
Alternative activation of macrophages | Q27860939 | ||
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma | Q28118779 | ||
MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma. | Q41962867 | ||
Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor | Q42408332 | ||
GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. | Q42453025 | ||
Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma | Q42840163 | ||
Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth | Q43262197 | ||
MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. | Q44738304 | ||
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma | Q45361542 | ||
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression | Q46131735 | ||
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway | Q46255425 | ||
Stromal signatures in endometrioid endometrial carcinomas. | Q46544116 | ||
MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 | ||
Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. | Q47829471 | ||
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. | Q51889153 | ||
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. | Q53332426 | ||
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. | Q53343023 | ||
Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. | Q54457644 | ||
Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation | Q80088055 | ||
Hepatocellular carcinoma surgery--review of the past and prospects for the 21st century | Q80390886 | ||
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma | Q81351659 | ||
Role of tumor-associated macrophages in the angiogenesis of well-differentiated hepatocellular carcinoma: pathological-radiological correlation | Q87690862 | ||
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
Macrophages, innate immunity and cancer: balance, tolerance, and diversity | Q29614352 | ||
Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
Hepatocellular carcinoma | Q29616359 | ||
miR-150 regulates the development of NK and iNKT cells | Q30426423 | ||
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 | Q34207989 | ||
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma | Q34964774 | ||
MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta | Q35011103 | ||
MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma | Q35032496 | ||
Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour | Q35116221 | ||
Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages | Q35201643 | ||
The origin and function of tumor-associated macrophages | Q35352864 | ||
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection | Q35584172 | ||
Salmonella enterica serovar enteritidis modulates intestinal epithelial miR-128 levels to decrease macrophage recruitment via macrophage colony-stimulating factor | Q35785051 | ||
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 | ||
miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression | Q36294124 | ||
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer | Q36938409 | ||
The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster | Q37204707 | ||
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. | Q37273173 | ||
Tumour angiogenesis regulation by the miR-200 family | Q37523569 | ||
Cellular and molecular pathways linking inflammation and cancer | Q37555395 | ||
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation | Q37594369 | ||
The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. | Q37800217 | ||
Cancer-promoting tumor-associated macrophages: new vistas and open questions | Q37939626 | ||
Colony stimulating factors and myeloid cell biology in health and disease. | Q38045643 | ||
A brief primer on microRNAs and their roles in angiogenesis | Q38074494 | ||
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis | Q38484188 | ||
Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization | Q38664679 | ||
Zoledronic acid inhibits growth of hepatocellular carcinoma cells in vitro and in vivo | Q39164427 | ||
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. | Q39227433 | ||
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. | Q39689403 | ||
High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. | Q39919869 | ||
Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes | Q40152048 | ||
Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. | Q40174245 | ||
Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse | Q41169577 | ||
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages | Q41481421 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
macrophage | Q184204 | ||
P304 | page(s) | 56 | |
P577 | publication date | 2015-05-29 | |
P1433 | published in | Journal of Hematology & Oncology | Q15724593 |
P1476 | title | microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma | |
P478 | volume | 8 |
Q91890782 | A Review of Macrophage MicroRNAs' Role in Human Asthma |
Q99630106 | Anaesthesia and cancer: can anaesthetic drugs modify gene expression? |
Q91986368 | Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis |
Q64112454 | Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer |
Q26772718 | Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNS |
Q91951381 | Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets |
Q37728657 | Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer |
Q60948600 | Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication |
Q48182981 | Lung Epithelial Cell-Derived Microvesicles Regulate Macrophage Migration via MicroRNA-17/221-Induced Integrin β1 Recycling. |
Q90402489 | Macrophages and hepatocellular carcinoma |
Q39454807 | Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation |
Q26770275 | MicroRNA Targeting to Modulate Tumor Microenvironment |
Q49790324 | MicroRNA-26a and Tumor |
Q36433424 | MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. |
Q90479399 | MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers |
Q92392214 | MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages |
Q37440060 | Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition |
Q51767137 | NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. |
Q26801357 | Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer |
Q50353766 | Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish. |
Q39280710 | Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy |
Q37596666 | Role of microRNAs in inflammation-associated liver cancer |
Q49634844 | The role of macrophage phenotype in regulating the response to radiation therapy |
Q39403895 | Tumor-Associated Macrophages as Target for Antitumor Therapy. |
Q37671174 | Tumor-associated macrophages: from basic research to clinical application |
Q33889070 | Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis. |
Q51182190 | miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers. |
Q38824771 | miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor |
Search more.